LocumTenens.com Recognized for Service Excellence with ClearlyRated’s 2026 Staffing Awards
LocumTenens.com Wins ClearlyRated’s 2026 Best of Staffing Client and Talent Awards for Service Excellence LocumTenens.com, a pioneer in healthcare staffing solutions, announced today that it has won ClearlyRated’s Best of Staffing® Awards in both the Client and Talent categories. Marking the organization’s 13th consecutive…
Worldwide Clinical Trials Finalizes Acquisition of Catalyst Clinical Research
Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research Worldwide Clinical Trials a global contract research organization (CRO), has completed its acquisition of Catalyst Clinical Research, LCC (“Catalyst”) – a specialized oncology CRO and scalable functional service provider (FSP). This strategic transaction creates a…
ECCO Data Highlight Remsima™ SC’s Ability to Restore and Sustain Disease Control After Treatment Break
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday Celltrion, Inc. today announced new data from a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC), showing that subcutaneous (SC) infliximab…
MEDIPOST Inc. Submits IND Amendment to FDA to Begin Phase III Study
MEDIPOST Inc. Submits IND Amendment With U.S. Food and Drug Administration to Initiate Phase III Trial MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative diseases, announced today that it has filed an…
Enrollment Completed in Alto Neuroscience’s Phase 2 Proof-of-Concept Trial of ALTO-101
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia Alto Neuroscience, Inc. a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the…
Veradigm Launches New Survey Solution to Integrate Patient Perspectives into Healthcare Research
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution Veradigm a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly…
Anebulo Pharmaceuticals Shares Q2 FY2026 Financial Performance and Corporate Highlights
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates Anebulo Pharmaceuticals, Inc. a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced financial results for the…
Encora Therapeutics Wins FDA Clearance for Encora X1™ Breakthrough Tremor Device
Encora Therapeutics Receives FDA 510(k) Clearance for Encora X1™, a Breakthrough Wearable Device for Essential Tremor Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the…
KalVista Pharmaceuticals Showcases EKTERLY® Data at AAAAI 2026 Annual Meeting
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals, Inc. today announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology…
Dave & Cheryl Duffield Foundation Funds Yes to Care Collaboration with $1.9M Grant
Dave & Cheryl Duffield Foundation Provides $1.9M Grant for Yes to Care Program, a Collaboration to Improve Access to Veterinary Care Open Door Veterinary Collective has announced a $1.9 Million grant from the Dave & Cheryl Duffield Foundation, a private…
Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Automated Molecular Design
Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis Zeon Corporation (Zeon; head office: Chiyoda-ku, Tokyo; President and CEO: Tetsuya Toyoshima), through its venture…
iProov Dynamic Liveness Sets Industry First with Top Injection Attack Detection Certifications
iProov Dynamic Liveness Is the First and Only Solution to Achieve CEN/TS 18099 High and Ingenium Level 4 for Injection Attack Detection iProov, the world’s leading provider of science-based biometric identity verification solutions, today announced that its Dynamic Liveness technology…